Y-mAbs Therapeutics, Inc. (NASDAQ:YMAB) Q4 2022 Earnings Call Transcript

Y-mAbs Therapeutics, Inc. (NASDAQ:YMAB) Q4 2022 Earnings Call Transcript March 31, 2023

Operator: Good morning, and welcome to the Y-mAbs Therapeutics, Inc.’s Earnings Call for the Fourth Quarter 2022. As a reminder, today’s conference will be recorded. Let me quickly remind you that the following discussion contains certain statements that are considered forward-looking statements as defined in the Private Securities Litigation Reform Act of 1995. Such statements include, but are not...